| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2020 | Biotech Target N V55 | 10% Owner | Buy | 200,000 | $25.31 | $5,062,120.00 | +5.3% | |
| Mar 11, 2020 | Mayleben Timothy M | President &CEO | Buy | 2,500 | $43.00 | $107,500.00 | +2.3% | |
| Feb 28, 2020 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $49.00 | $245,000.00 | +4.8% | |
| Jan 23, 2020 | Biotech Target N V55 | 10% Owner | Buy | 20,000 | $52.12 | $1,042,398.00 | +0.5% | |
| Nov 6, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $36.98 | $184,900.00 | +6.4% | |
| Nov 6, 2019 | Biotech Target N V55 | 10% Owner | Buy | 75,000 | $37.30 | $2,797,560.00 | +2.1% | |
| Sep 6, 2019 | Mayleben Timothy M | President &CEO | Buy | 7,500 | $34.55 | $259,106.60 | +3.4% | |
| Sep 4, 2019 | Biotech Target N V55 | 10% Owner | Buy | 80,000 | $33.78 | $2,702,208.00 | +2.2% | |
| Aug 1, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $39.56 | $197,800.00 | +7.6% | |
| Jul 23, 2019 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $42.65 | $2,132,565.00 | +1.4% |